Publications

Recent Publications

Innovative Approaches for Managing Relapsed or Refractory Peripheral T-cell Lymphoma

Brian T. Grainger, Joshua Casan, Chathuri Abeyakoon, Salvia Jain, H. Miles Prince
Expert Opinion On Pharmacotherapy  
doi.org/10.1080/14656566.2026.2667326

Allogeneic Transplant Outcomes in T-cell Prolymphocytic Leukemia: a Single-center Retrospective Study

Mwanasha Merrill, Haesook T. Kim, Amar H. Kelkar, Kevin Panaro, Rakuyo Tamada, Chloe Au, Shambhavi Singh, Akil Vicks, Salvia Jain, Jerome Ritz, Vincent T. Ho, Eric Jacobsen.
Leukemia and Lymphoma doi.org/10.1080/10428194.2026.2645933

Clinical Outcomes of Mature T- and NK-Cell Lymphomas in Hepatitis B Virus Positive Individuals: Results from the PETAL Global Consortium

Colin Thomas, Min Jung Koh, Omar Elghawy, Jessy Xinyi Han, Leora Boussi, Mark Sorial, Sean McCabe, Luke Peng, Shambhavi Singh, ljeoma Julie Eche-Ugwu, Judith Gabler, Maria Fernandez Turizo, Caroline MacVicar, Alexander Disciullo, Kusha Chopra, Alexandra Lenart, Emmanuel Nwodo, Jeffrey Barnes, Min Ji Koh, Eliana Miranda, Carlos Chiattone, Robert Stuver, Mwanasha Merrill, Eric Jacobsen, Jin Seok Kim, Yuri Kim, Jae Yong Cho, Thomas Eipe, Tanuja Shet, Epari Sridhar, Alok Shetty, Saswata Saha, Hasmukh Jain, Manju Sengar, Carrie Van Der Weyden, Henry Miles Prince, Ramzi Hamouche, Tinatin Murdashvili, Francine Foss, Marianna Gentilini, Beatrice Casadeir, Pier Luigi Zinzani, Takeshi Okatani, Noriaki Yoshida, Sang Eun Yoon, Won Seog Kim, Girisha Panchoo, Zainab Mohamed, Estelle Verburgh, Jackielyn Cuenca Alturas, Mubarak Al Mansour, Josie Ford, Martina Manni, Monica Civallero, Tetiana Skrypets, Massimo Federico, Maria Elena Cabrera, Govind Bhagat, Helen Ma, Ahmed Sawas, Makoto Iwasaki, Forum Bhanushali, Riya Bhattacharjee, Khyati Maulik Kariya, Owen O'Connor, Omar Abduljaleel, Anupa John, Athina Lymboussaki, Changyu Shen, Emma DeMarco, Devavrat Shah, Dhruv Mistry, Erica Lee, Grace Sun, Ellen Kendall, Enrica Marchi, Maya Krishnan, Kristiana Nasto, Corben Yuwai Wong, Salvia Jain, Stefan Barta.
Leukemia and Lymphoma doi.org/10.1080/10428194.2026.2629953

Early time to relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL Consortium

Mark Sorial, Luis Malpica, Carlos Sergio Chiattone, Edith Julia, Emmannuel Bachy, Stefan Barta, Robert Stuver, Eric Jacobsen, Massimo Federico, Hasmukh Jain, H. Miles Prince, Francine Foss, Pier Luigi Zinzani, Takeshi Okatani, Won Seog Kim, Estelle Verburgh, Mubarak Al- Mansour, Maria Elena Cabrera, Govind Bhagat, Devavrat Shah, Changyu Shen, Salvia Jain.
Blood blood.2025030149.

Real-world Evidence of Duvelisib and Romidepsin in
Relapsed/Refractory Peripheral and Cutaneous T-cell
Lymphomas

Josie Ford, Min Jung Koh, Alexandra W. Lenart, Caroline T MacVicar, Kusha Chopra, Arushi Meharwal, Mark N Sorial, Mwanasha H Merrill, Anna Baird Rider, Aliyah Sohani, Sean Michael McCabe, Ronald A Nemec, Makoto Iwasaki, Dhruv Mistry, Khyati Maulik Kariya, Steven Chen, Jeffrey A. Barnes, Steven McAfee, Yi-Bin Chen, Corben Yuwai Wong, Kristiana Nasto, Eric D. Jacobsen, Salvia Jain
Blood Adv bloodadvances.2025016347.

Forecasting optimal treatments in relapsed/refractory
mature T- and NK-cell lymphomas: A global PETAL
Consortium study

Mark N. Sorial, Jessy Xinyi Han, Min Jung Koh, Leora Boussi, Sijia Li, Rui Duan, Junwei Lu, Matthew M. Lei, Caroline T. MacVicar, Jessica Freydman, Jack Malespini, Kenechukwu N. Aniagboso, Sean M. McCabe, Luke Peng, Shambhavi Singh, Makoto Iwasaki, ljeoma Julie Eche-Ugwu, Judith Gabler, Maria J. Fernandez Turizo, Aditya Garg, Alexander Disciullo, Kusha Chopra, Josie Ford, Alexandra Lenart, Emmanuel Nwodo, Jeffrey Barnes, Min Ji Koh, Eliana Miranda, Carlos Chiattone, Robert Stuver, Mwanasha Merrill, Eric Jacobsen, Martina Manni, Monica Civallero, Tetiana Skrypets, Athina Lymboussaki, Massimo Federico, Yuri Kim, Jin Seok Kim, Jae Yong Cho, Thomas Eipe, Tanuja Shet, Sridhar Epari, Alok Shetty, Saswata Saha, Hasmukh Jain, Manju Sengar, Carrie Van Der Weyden, Henry Miles Prince, Ramzi Hamouche, Tinatin Muradashvili, Francine Foss, Marianna Gentilini, Beatrice Casadei, Pier Luigi Zinzani, Takeshi Okatani, Noriaki Yoshida, Sang Eun Yoon, Won-Seog Kim, Girisha Panchoo, Zainab Mohamed, Estelle Verburgh, Jackielyn Cuenca Alturas, Mubarak Al-Mansour, Maria Elena Cabrera, Amy Ku, Govind Bhagat, Helen Ma, Ahmed Sawas, Khyati Maulik Kariya, Forum Bhanushali, Arushi Meharwal, Dhruv Mistry, Maria Kosovsky, Mesrob Yeterian, Owen A. O'Connor, Enrica Marchi, Changyu Shen, Devavrat Shah, Salvia Jain
Br J Haematol. 2025; 206(6): 1664-1677.

Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: Results from PETAL consortium

Jessy Xinyi Han, Min Jung Koh, Leora Boussi, Mark Sorial, Sean Michael McCabe, Luke Peng, Shambhavi Singh, ljeoma Julie Eche-Ugwu, Judith Gabler, Maria J. Fernandez Turizo, Caroline T MacVicar, Aditya Ramesh Garg, Alexander Disciullo, Kusha Chopra, Alexandra W. Lenart, Emmanuel Nwodo, Jeffrey A. Barnes, Min Ji Koh, Eliana C M Miranda, Carlos Sergio Chiattone, Robert N Stuver, Steven M Horwitz, Mwanasha H Merrill, Eric D. Jacobsen, Martina Manni, Monica Civallero, Tetiana Skrypets, Athina Lymboussaki, Massimo Federico, Yu Ri Kim, Jin Seok Kim, Jae Yong Cho, Thomas Eipe, Tanuja Shet, Dr., Sridhar Epari, Alok Shetty, Saswata Saha, Hasmukh Jain, Dr., Manju Sengar, MD, DM, Carrie Van Der Weyden, H Miles Prince, Ramzi Hamouche, Tinatin Muradashvili, Francine M Foss, Marianna Gentilini, Beatrice Casadei, Pier Luigi Zinzani, Takeshi Okatani, Noriaki Yoshida, Sang Eun Yoon, Won Seog Kim, Girisha Panchoo, Zainab Mohamed, Estelle Verburgh, Jackielyn Cuenca Alturas, Mubarak Al- Mansour, Josie Ford, Maria Elena Cabrera, Amy Ku, Govind Bhagat, Helen Ma, Ahmed Sawas, Khyati Maulik Kariya, Makoto Iwasaki, Forum Bhanushali, Owen A. O'Connor, Enrica Marchi, Changyu Shen, Devavrat Shah, Salvia Jain
Blood Adv bloodadvances.2024014674.

KLRG1 Cell Depletion As A Novel Therapeutic Strategy In Patients With Mature T-cell lymphoma Subtypes.

Assatova B, Willim R, Trevisani C, Haskett G, Kariya KM, Chopra K, Park SR, Tolstorukov MY, McCabe SM, Duffy J, Louissaint A, Huuhtanen J, Bhattacharya D, Mustjoki S, Koh MJ, Powers F, Morgan EA, Yang L, Pinckney B, Cotton MJ, Crabbe A, Ziemba JB, Brain I, Heavican-Foral TB, Iqbal J, Nemec R, Rider AB, Ford JG, Koh MJ, Scanlan N, Feith DJ, Loughran TP, Kim WS, Choi J, Roels J, Boehme L, Putteman T, Taghon T, Barnes JA, Johnson PC, Jacobsen ED, Greenberg SA, Weinstock DM, Jain S.
Clin Cancer Res. 2024 Jan 22. doi: 10.1158/1078-0432.CCR-23-3504. Online ahead of print.PMID: 38252421

Comparative efficacy and tolerability of novel agents versus chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis.

Shafagati N, Stuver R, Boussi L, Koh MJ, Park A, Bain P, Foss FM, Shen c, Jain S.
Blood Adv. 2022; DOI: Link. PMID: 35816645.

Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS- defining lymphomas

Koh MJ, Merrill MH, Koh MJ, Stuver R, Alonso CD, Foss FM, Mayor AM, Gill JS,Epeldegui M, Cachay E, Thorne JE, Silverberg MJ, Horberg MA, Atlhoff KN, Nijhawan AE, McGinnis KA, Lee JS, Rabkin CS, Napravnik S, Li J, Castilho JL, Shen C, Jain S.
Blood Adv. 2022; 6(5):1420-1431. PubMed Central PMCID: PMC8905704.

Targeted inhibition of CD47-SIRP alpha requires Fc-FcGR interactions to maximize activity in T-cell lymphomas.

Jain S, Van Scoyk A, Morgan EA, Matthews A, Stevenson K, Newton G, Powers F, Autio A, Louissaint A Jr, Pontini G, Aster JC, Luscinskas FW, Weinstock DM
Blood. 2019;134(17):1430-1440. PubMed Central PMCID: PMC31383641.

Single agents vs. combination chemotherapy in relapsed and refractory peripheral T- cell lymphoma: results from the comprehensive oncology measures for peripheral T- cell lymphoma treatment (COMPLETE) registry.

Stuver RN, Khan N, Schwartz M, Acosta M, Federico M, Gisselbrecht C, Horwitz SM, Lansigan F, Pinter- Brown LC, Pro B, Shustov AR, Foss FM, Jain S.
Am J Hematol. 2019; 94(6):641-649. PubMed Central PMCID: PMC30896890.

Decitabine priming enhances Mucin 1 inhibition mediated disruption of redox hemostasis in cutaneous T-cell lymphoma.

Jain S, Washington A, Leaf RK, Bhargava P, Clark RA, Kupper TS, Stroopinsky D, Pyzer A, Cole L, Nahas M, Apel A, Rosenblatt J, Arnason J, Kufe D, Avigan D.
Mol Cancer Ther. 2017; 16(10):2304-2314. PubMed Central PMCID: PMC28729399.

Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma.

Jain S, Stroopinsky D, Yin L, Rosenblatt J, Alam M, Bhargava P, Clark RA, Kupper TS, Palmer K, Coll MD, Rajabi H, Pyzer A, Bar-Natan M, Luptakova K, Arnason J, Joyce R, Kufe D, Avigan D.
Blood. 2015; 126(3):354-62. PubMed Central PMCID: PMC26048911.

Preclinical Pharmacologic Evaluation of Pralatrexate and Romidepsin Confirms Potent Synergy of the Combination in a Murine Model of Human T-cell Lymphoma.

Jain S, Jirau-Serrano X, Zullo KM, Scotto L, Palermo CF, Sastra SA, Olive KP, Cremers S, Thomas T, Wei Y, Zhang Y, Bhagat G, Amengual JE, Deng C, Karan C, Realubit R, Bates SE, O'Connor OA.
Clin Cancer Res. 2015; 21(9):2096-106. PubMed Central PMCID: PMC25677697.